Assertio Therapeutics, Inc 3 SEC Filings

Filed On	Filing
01 Oct 2019	Form 3: Wheadon David E., Director Holds 0 shares of Common Stock
02 Apr 2019	Form 3: Galeota James Jr, Director Holds 0 shares of Common Stock
19 Feb 2019	Form 3: Mason Heather L, Director Holds 0 shares of Common Stock
04 Dec 2018	Form 3: Peisert Daniel A., SVP and CFO Holds 10,975 shares of Common Stock
16 Jul 2018	Form 3: Donenberg Phillip B., SVP and CFO Holds 0 shares of Common Stock
04 Apr 2018	Form 3: Bukofzer Stan, Chief Medical Officer & SVP*** No securities owned
18 Oct 2017	Form 3: Vetticaden Santosh, SVP, Chief Medical Officer *** No securities owned
04 Apr 2017	Form 3: Higgins Arthur J, Director Holds 1,000 shares of Common Stock
30 Mar 2017	Form 3: Molinelli Gavin, Director Holds 4,038,987 shares of Common Stock, no par value
30 Mar 2017	Form 3: Mckee William, Director No securities owned
19 Oct 2016	Form 3: Savage Robert G., Director Holds 0 shares of Common Stock
19 Oct 2016	Form 3: Fogarty James P, Director Holds 16,450 shares of Common Stock
19 Oct 2016	Form 3: Tyree James L, Director Holds 0 shares of Common Stock
04 Sep 2014	Form 3: Shively Richard Scott, Chief Commercial Officer Holds 0 shares of Common Stock
18 Jul 2014	Form 3: Srinivas Rao, Chief Medical Officer Holds 0 shares of Common Stock
09 Jul 2013	Form 3: Lavigne Louis J Jr, Director Holds 0 shares of Common Stock
11 Feb 2013	Form 3: Anido Vicente Jr, Director Holds 0 shares of Common Stock
09 Oct 2012	Form 3: Saks Samuel R, Director Holds 0 shares of Common Stock
04 Jan 2012	Form 3: Moretti August J, Chief Financial Officer Holds 0 shares of Common Stock
02 Sep 2011	Form 3: Vargas Thadd M, Senior VP, BD

Comments